Related Experiment Video
Updated: Mar 15, 2026
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Three-Dimensional Spheroid Cell Culture Model for Target Identification Utilizing High-Throughput RNAi Screens
LaKesla R Iles1, Geoffrey A Bartholomeusz2
1Division of Cancer Medicine, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 77054, USA.
Abstract:
The intrinsic limitations of 2D monolayer cell culture models have prompted the development of 3D cell culture model systems for in vitro studies. Multicellular tumor spheroid (MCTS) models closely simulate the pathophysiological milieu of solid tumors and are providing new insights into tumor biology as well as differentiation, tissue organization, and homeostasis. They are straightforward to apply in high-throughput screens and there is a great need for the development of reliable and robust 3D spheroid-based assays for high-throughput RNAi screening for target identification and cell signaling studies highlighting their potential in cancer research and treatment. In this chapter we describe a stringent standard operating procedure for the use of MCTS for high-throughput RNAi screens.
Insights
Three-dimensional (3D) multicellular tumor spheroids (MCTS) offer a more realistic in vitro model for cancer research. This work details a robust MCTS method for high-throughput RNAi screening in cancer studies.
Area of Science:
- Biotechnology
- Cell Biology
- Cancer Research
Background:
- Traditional 2D cell cultures have limitations in mimicking the tumor microenvironment.
- Three-dimensional (3D) cell culture models, such as multicellular tumor spheroids (MCTS), offer a more physiologically relevant in vitro system.
- MCTS provide insights into tumor biology, tissue organization, and homeostasis.
Purpose of the Study:
- To establish a reliable and robust 3D spheroid-based assay for high-throughput RNA interference (RNAi) screening.
- To facilitate target identification and cell signaling studies in cancer research.
- To present a stringent standard operating procedure for MCTS application in high-throughput RNAi screens.
Main Methods:
- Development and validation of a standard operating procedure for generating and utilizing MCTS.
- Application of MCTS in high-throughput RNAi screening platforms.
- Focus on stringent protocols for reliable and reproducible results.
Main Results:
- Demonstration of MCTS as a suitable model for high-throughput RNAi screening.
- Highlighting the utility of MCTS for studying cancer biology and signaling pathways.
- Establishing a reproducible methodology for MCTS-based assays.
Conclusions:
- MCTS models represent a significant advancement over 2D cultures for in vitro cancer research.
- The described MCTS protocol enables efficient high-throughput RNAi screening for target discovery.
- This approach holds promise for accelerating cancer research and therapeutic development.
